The studies about the role of miRNAs and other non-coding RNAs in NB development and therapy resistance, as well as their expression regulation by MYCN, are too numerous to comprehensively describe in this review and have been extensively reviewed in these articles [111–115]. This evidence concerns the gene MYCN and neuroblastoma.